KRRO Korro Bio, Inc.
Healthcare$11.61+3.66%ClosedMarket Cap: $115.6M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.13
P/S
30.08
EV/EBITDA
-1.24
DCF Value
$-0.53
FCF Yield
-61.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
73.2%
Operating Margin
-2154.0%
Net Margin
-2954.1%
ROE
-117.9%
ROA
-61.8%
ROIC
-48.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-20.4M | $-19.6M | $— | — |
| Q4 null | $1.3M | 49.8% | $-15.9M | $-50.0M | $— | — |
| FY null | $6.4M | 33.0% | $-87.3M | $-117.3M | $— | — |
| Q3 null | $1.1M | 100.0% | $-19.2M | $-18.1M | $— | — |
| Q2 null | $1.5M | 100.0% | $-27.2M | $-25.8M | $— | — |
| Q1 null | $2.5M | 100.0% | $-25.0M | $-23.4M | $— | — |
| Q4 null | $2.3M | 100.0% | $-23.0M | $-21.2M | $— | — |
| FY null | $2.3M | 100.0% | $-91.9M | $-83.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-23.3M | $-21.0M | $— | — |
| Q2 null | $0.00 | NaN% | $-24.1M | $-21.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-21.5M | $-19.6M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-26.9M | $-25.4M | $-4.89 | — |